Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,335 recruiting studies in this area right now.
By phase
- Not applicable4,398
- Phase 2610
- Phase 1411
- Phase 3321
- Phase 4271
- Phase 1/Phase 2254
- Phase 2/Phase 370
Top conditions
- Ovarian Cancer338
- Cervical Cancer232
- Endometrial Cancer206
- Bladder Cancer190
- Acute Kidney Injury137
- Endometriosis135
- Pregnancy132
- Chronic Kidney Diseases131
- Breast Cancer107
- Chronic Kidney Disease105
- Infertility94
- Renal Cell Carcinoma81
- Colorectal Cancer74
- Preeclampsia73
- Pregnancy Related72
- Prostate Cancer65
- Pregnancy Complications63
- Urinary Incontinence63
Leading sponsors
- Mayo Clinic58
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS48
- Assistance Publique - Hôpitaux de Paris47
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- M.D. Anderson Cancer Center45
- National Cancer Institute (NCI)41
- University of Colorado, Denver39
- Chinese University of Hong Kong38
- University of Aarhus36
- AstraZeneca35
Where studies are running
- California345
- Alabama155
- Texas121
- Massachusetts119
- New York118
- Florida103
- Arizona100
- Colorado90
- Maryland89
- Illinois78
Recruiting studies6,335 total
- NCT07149519Recruiting
Diet and probiotics for endometriosis and IBS
This study tests whether dietary guidance and probiotics can help women with endometriosis and irritable bowel syndrome (IBS). It aims to see if these treatments improve symptoms and quality of life.
Catanduva, São PauloAges 15–50 - NCT07150884Recruiting
Lactase supplement study for weight gain in preterm infants
This trial tests whether giving lactase (a natural enzyme that helps digest milk sugar) to preterm babies helps them gain weight better. It is for infants born between 28 and 34 weeks of pregnancy who get most of their nutrition through the gut.
ThessalonikiAges 1 day–4 weeks - NCT07151274Recruiting
Ehlers-Danlos syndrome and women's gynecological health
This study uses an online questionnaire to explore how Ehlers-Danlos syndrome (EDS) may affect gynecological health. It compares women with EDS to those without, to better understand any differences.
RouenAges 18–50 - NCT07151339Recruiting
Preventing heart and kidney issues after preeclampsia
This study tests a new approach to prevent long-term heart and kidney problems in people who had preeclampsia, HELLP syndrome, or kidney disease during pregnancy. It aims to see if early follow-up care can improve future health.
KielAges 18 years+ - NCT07152106Recruiting
Amniotic fluid and the preterm baby's gut
This study looks at the fluid around your baby (amniotic fluid) and how it might affect your baby's gut health if they are born early. It may help doctors understand how to better care for preterm infants.
AmsterdamAges 16 years+ - NCT07153432Recruiting
Chronic kidney disease screening for at-risk adults
This study is a simple screening to check for early signs of chronic kidney disease. It aims to find kidney problems in people who are at higher risk due to age or other health conditions.
PragueAges 18 years+ - NCT07154134Recruiting
Blood markers in preterm babies with breathing problems
This study looks at two substances in the blood (endocan and copeptin) to see if they can help doctors understand breathing problems in premature babies. It may lead to better ways to care for these infants.
Tanta, El-GharbiaAges 6 months–8 months - NCT07154186Recruiting
Triglyceride glucose index in premature heart disease patients
This trial studies whether a simple blood test called the triglyceride glucose index can help doctors understand heart artery disease in younger patients who do not have diabetes. It may lead to better ways to assess heart risk and guide treatment.
SohagAges 18 years+ - NCT07156253RecruitingPhase 1
Study of SYN818 with olaparib for advanced solid tumors
This trial is testing a new drug, SYN818, combined with olaparib for people with advanced solid tumors that have certain genetic changes (BRCA mutations or related DNA repair problems). It may be an option if you have ovarian or HER2-negative breast cancer and other treatments are no longer working.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07157397Recruiting
Plant-based diet for nutrition on dialysis
This study tests if eating more plant-based foods can improve nutrition in people on peritoneal dialysis who are underweight or malnourished. Participants will follow a special diet plan and have regular health check-ups for 6 months.
Cheras, Kuala LumpurAges 18 years+ - NCT07158723Recruiting
Protein and PCOS study for women
This trial tests how eating different types of protein affects women with PCOS. It may help you understand how your body responds to plant versus animal protein.
Fayetteville, ArkansasAges 18–50 - NCT07159555Recruiting
Neurofilament levels in late preterm newborns
This study looks at a substance in the blood called neurofilaments, which may help doctors understand early brain development in babies born a few weeks early. If your baby already needs a blood test, researchers will use a small extra sample to learn more.
LiègeAges Up to 3 weeks - NCT07159880Recruiting
Letrozole for ovulation induction in PCOS
This trial tests a longer course of letrozole to help women with PCOS ovulate and get pregnant. The goal is to see if extended therapy works better than the standard treatment.
São Paulo, São PauloAges 18–40 - NCT07160855RecruitingPhase 4
Adding letrozole to standard miscarriage treatment
This trial tests whether adding letrozole (a hormone pill) to misoprostol (a medicine to complete a miscarriage) works better than misoprostol alone for ending a missed miscarriage in early pregnancy. It aims to make the process safer and possibly faster.
Multan, Punjab ProvinceAges 18–45 - NCT07163611RecruitingPhase 2/Phase 3
Obinutuzumab for PLA2R antibodies in membranous nephropathy
This study is testing a drug called obinutuzumab to see if it can lower PLA2R antibodies in people with membranous nephropathy (a kidney disease). The goal is to reduce protein leakage in urine and improve kidney health.
NijmegenAges 18 years+ - NCT07164183RecruitingPhase 3
Comparing two drugs for endometriosis pain relief
This study tests if a new drug called Indinol Forto works as well as the standard drug Visanne for reducing endometriosis-related pelvic pain. It is for women with surgically confirmed endometriosis who have regular cycles and moderate to severe pain.
Kazan'Ages 18–45 - NCT07165236Recruiting
Bladder tumor surgery and memory changes study
This study looks at how bladder tumor surgery might affect thinking and memory. It checks blood markers to see if they are linked to any mental changes after the operation.
Osijek, CroatiaAges 18–80 - NCT07166445Recruiting
Using AI to read kidney cancer CT scans for better staging
This study uses a computer program (deep learning) to look at your kidney CT scan and tell if your cancer is more advanced (stage T3) or earlier (stage T1-T2). The goal is to help doctors plan the best treatment for you.
BeijingAges 18–85 - NCT07167160RecruitingPhase 2
Chemo-immune therapy for stage IIICp cervical cancer
This trial tests a combination of chemotherapy and immunotherapy for patients with cervical cancer that has spread to pelvic lymph nodes (stage IIICp) after radical surgery. It aims to improve outcomes by boosting the immune system's ability to fight remaining cancer cells.
Hangzhou, ZhejiangAges 18–70 - NCT07167329RecruitingPhase 2
Belzutifan for VHL syndrome: a real-world study
This trial tests the drug belzutifan (a pill taken by mouth) in people with VHL syndrome who have kidney or other VHL-related tumors that are growing or can be measured. The study looks at how well belzutifan works in real-world conditions and whether certain genetic factors affect how the drug works.
São Paulo, São PauloAges 14 years+ - NCT07167368Recruiting
Exercise rehab for heart and kidney health
This trial tests whether a supervised exercise program can help people with heart failure and mild-to-moderate kidney problems. It might improve both your heart and kidney function.
Nantong, JiangsuAges 18–75 - NCT07169214RecruitingPhase 1
Study of BT-114143 injection for heavy menstrual bleeding
This trial tests an investigational medication called BT-114143 for people with heavy menstrual bleeding (abnormal uterine bleeding). The goal is to see if it is safe and effective in reducing blood loss during periods.
Beijing, Beijing MunicipalityAges 18–50 - NCT07169396Recruiting
Genetic study for ovarian cancer treatments
This study looks at genetic changes in ovarian cancer to find possible targeted treatments. It may help you if you have certain types of ovarian cancer and are seeking more personalized care.
Reggio EmiliaAges 18 years+ - NCT07169422Recruiting
Pharmacist prescribing for kidney care in type 2 diabetes
This study tests whether having a pharmacist prescribe kidney-protective medications works better than usual care for people with type 2 diabetes and early kidney disease. If you don't have a family doctor, you may be able to get these medications more easily through a pharmacist.
Halifax, Nova ScotiaAges 18 years+
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,335 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 10,288 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.